Deal facts
- Buyer
- KKR
- Target
- IMMEDICA
- Deal value
- Not disclosed
- Announced
- 29 July 2024
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
KKR has agreed to acquire IMMEDICA, a healthcare company, in a private equity acquisition announced on 29 July 2024. The transaction involves the purchase of the target business by the investment firm, though the specific financial consideration and currency were not disclosed in the available records. No details regarding the countries of operation for either party were reported in the source data.
The deal remains in the review phase as of the latest update, pending further developments before completion. Regulatory approval and other standard conditions must be satisfied before the transaction can be finalised. The management team continues to operate the business while the acquisition process proceeds through the necessary legal and administrative stages.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
KKR / IMPILO / IMMEDICA
KKR / IMPILO / IMMEDICA
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
CCP PAW 2 LIMITED to acquire Animalcare Group plc
CCP PAW 2 LIMITED has agreed to acquire Animalcare Group plc in a private equity acquisition valued at 235.2 million GBP. The transaction, announced on 16 April 2026, in…
- Buyer
- CCP PAW 2 LIMITED
- Target
- Animalcare Group plc
- Deal value
- GBP 235,200,000
- Deal type
- pe acquisition
BLACKSTONE / TPG to acquire HOLOGIC
BLACKSTONE / TPG and HOLOGIC entered the Exit Mode archive.
- Buyer
- BLACKSTONE / TPG
- Target
- HOLOGIC
- Deal value
- Not disclosed
- Deal type
- pe acquisition
BAIN CAPITAL / KOHLBERG to acquire PCI PHARMA GROUP
BAIN CAPITAL / KOHLBERG and PCI PHARMA GROUP entered the Exit Mode archive.
- Buyer
- BAIN CAPITAL / KOHLBERG
- Target
- PCI PHARMA GROUP
- Deal value
- Not disclosed
- Deal type
- pe acquisition
KKR to acquire KARO HEALTHCARE
KKR has agreed to acquire KARO HEALTHCARE in a private equity acquisition. The transaction was announced on 9 July 2025. The target operates within the NaceV2Sector_N_72…
- Buyer
- KKR
- Target
- KARO HEALTHCARE
- Deal value
- Not disclosed
- Deal type
- pe acquisition
HELLMAN & FRIEDMAN / CVC to acquire MEHILÄINEN
Hellman & Friedman and CVC have agreed to acquire Mehiläinen, a Finnish healthcare provider, in a private equity acquisition announced on 11 May 2025. The transaction in…
- Buyer
- HELLMAN & FRIEDMAN / CVC
- Target
- MEHILÄINEN
- Deal value
- Not disclosed
- Deal type
- pe acquisition
Buyer history
KKR
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive